Who is sponsoring NCT02978170?

NCT02978170 is sponsored by M.D. Anderson Cancer Center.

What drugs are being tested in NCT02978170?

Interventions in NCT02978170: Cone-Beam Computed Tomography.

What condition does NCT02978170 study?

NCT02978170 studies Pulmonary Mass.

Is NCT02978170 still recruiting?

NCT02978170 is currently completed. Last updated 4 June 2019.

Last reviewed 2019-06-04 · How we verify

NCT02978170

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

CBCT in Guiding Bronchoscopy in Patients With Lung Lesions

Completed NA Last updated 4 June 2019

What this trial tests

NA trial testing Cone-Beam Computed Tomography in Pulmonary Mass in 21 participants. Completed in 4 May 2019.

Timeline

28 November 2016

Primary endpoint
4 May 2019

4 May 2019

Quick facts

Lead sponsor	M.D. Anderson Cancer Center
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	21
Start date	28 November 2016
Primary completion	4 May 2019
Estimated completion	4 May 2019
Sites	1 location across United States

Drugs / interventions tested

Cone-Beam Computed Tomography

Conditions studied

Pulmonary Mass — all drugs for Pulmonary Mass →

Sponsor

M.D. Anderson Cancer Center — full company profile →

Who can join

18 and older, any sex, with Pulmonary Mass. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This pilot clinical trial studies how well cone-beam computed tomography (CBCT) works in guiding bronchoscopy in patients with lung lesions. CBCT during bronchoscopy may help doctors to biopsy lung lesions that are harder to reach.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Cone beam computed tomography-guided thin/ultrathin bronchoscopy for diagnosis of peripheral lung nodules: a prospective pilot study.
Casal RF, Sarkiss M, Jones AK, Stewart J, et al · · 2018 · cited 104× · PMID 30746241 · DOI 10.21037/jtd.2018.11.21

Verify or expand the search:

Other trials of Cone-Beam Computed Tomography

Trials testing the same drug.

NCT06954831 — Ultra-hypofractionated Whole Breast Irradiation With Lumpectomy Cavity Boost for the Treatment of Stage I-III Breast Can · Phase 2 · recruiting
NCT06325046 — Adaptive Radiation Therapy (ART) Stereotactic Ablative Body Radiotherapy (SABR) for Primary Localized Prostate Cancer · NA · recruiting
NCT03707925 — Bronchoscopic Laser Ablation of Peripheral Lung Tumors · NA · terminated
NCT03076255 — Using a Head and Neck Maskless Immobilization Device For Patients With Intracranial Tumors · NA · completed
NCT03053960 — Helical CT, PET/CT, MRI, and CBCT Alone or in Combination in Predicting Jaw Invasion in Patients With Oral Cancer · terminated

Other M.D. Anderson Cancer Center trials

Trials by the same sponsor.

NCT07053020 — A Phase 1b/2 Open-label, Dose-ranging Safety and Efficacy Study of Oral Cladribine in Patients With Acute Myeloid Leukem · Phase 1, PHASE2 · not yet recruiting
NCT07052994 — A Phase Ia/Ib Trial of Revumenib Combined With Cytarabine, Daunorubicin, and Gemtuzumab Ozogamicin (GO) in Frontline and · Phase 1 · not yet recruiting
NCT07137481 — Phase II Study of CD5 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Che · Phase 2 · not yet recruiting
NCT07162480 — Phase II Trial of Puxitatug Samrotecan (AZD8205) in Advanced, Recurrent or Metastatic (R/M) Aggressive Adenoid Cystic Ca · Phase 2 · not yet recruiting
NCT07076498 — Engineered HSV-1 M032 for the Treatment of Children and Adults With Newly Diagnosed Diffuse Midline Glioma After Standar · Phase 1 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02978170 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by M.D. Anderson Cancer Center
Last refreshed: 4 June 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02978170.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing